• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德尔塔中性粒细胞指数在预测需要重症监护的 COVID-19 患者 30 天死亡率中的疗效。

Efficacy of the delta neutrophil index in predicting 30-day mortality in COVID-19 patients requiring intensive care.

机构信息

Department of Surgery, Ankara City Hospital, Ankara, Turkey.

Department of Pulmonary Diseases, Ankara Abdurrahman Yurtaslan Oncology Hospital, Ankara, Turkey.

出版信息

Int J Clin Pract. 2021 May;75(5):e13970. doi: 10.1111/ijcp.13970. Epub 2021 Jan 6.

DOI:10.1111/ijcp.13970
PMID:33368905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7883061/
Abstract

OBJECTIVES

Coronavirus-19 is a rapidly progressing disease that can result in mortality. We aimed to evaluate the efficacy of the delta neutrophil index in predicting mortality in intensive care patients diagnosed with Coronavirus-19.

MATERIALS AND METHODS

Patients with a positive polymerase chain reaction test and/or computed tomography findings compatible with the disease were included in the study. The demographic characteristics of the patients, polymerase chain reaction test results, chest computed tomography findings, blood parameters at the time of presentation, 30-day mortality, and the number of days in the intensive care unit were assessed.

RESULTS

Of the 388 patients receiving intensive care, 220 (56.7%) were men and 168 (43.3%) were women. The mean age was 70 ± 15 years. The evaluation of mortality, 264 (68%) of the patients survived and 124 (32%) died. The delta neutrophil index, neutrophil lymphocyte ratio, lactate, interleukin-6 and C-reactive protein values were statistically significantly higher and the lymphocyte value was significantly lower in the mortality group (P = .003, .034, .000, .002, .000 and .024, respectively). In the receiver operating characteristic curve analysis, the area under the curve values of the delta neutrophil index, lymphocyte, neutrophil lymphocyte ratio, lactate, interleukin-6 and C-reactive protein levels in predicting mortality were 0.718, 0.416, 0.628, 0.585, 0.701 and 0.684, respectively.

CONCLUSION

We consider that the delta neutrophil index can be used as an effective prognostic parameter to show intensive care mortality in patients with Coronavirus-19.

摘要

目的

新冠病毒是一种快速发展的疾病,可导致死亡。我们旨在评估中性粒细胞 delta 指数在预测新冠肺炎重症监护患者死亡率方面的效果。

材料与方法

本研究纳入了聚合酶链反应检测阳性和/或符合疾病的计算机断层扫描结果的患者。评估了患者的人口统计学特征、聚合酶链反应检测结果、胸部计算机断层扫描结果、就诊时的血液参数、30 天死亡率和重症监护病房的天数。

结果

在接受重症监护的 388 名患者中,220 名(56.7%)为男性,168 名(43.3%)为女性。平均年龄为 70±15 岁。评估死亡率时,264 名(68%)患者存活,124 名(32%)死亡。死亡率组的中性粒细胞 delta 指数、中性粒细胞与淋巴细胞比值、乳酸、白细胞介素-6 和 C 反应蛋白值显著较高,淋巴细胞值显著较低(P=.003、.034、.000、.002、.000 和.024)。在受试者工作特征曲线分析中,中性粒细胞 delta 指数、淋巴细胞、中性粒细胞与淋巴细胞比值、乳酸、白细胞介素-6 和 C 反应蛋白水平预测死亡率的曲线下面积值分别为 0.718、0.416、0.628、0.585、0.701 和 0.684。

结论

我们认为,中性粒细胞 delta 指数可作为一种有效的预后参数,用于显示新冠肺炎重症监护患者的死亡率。

相似文献

1
Efficacy of the delta neutrophil index in predicting 30-day mortality in COVID-19 patients requiring intensive care.德尔塔中性粒细胞指数在预测需要重症监护的 COVID-19 患者 30 天死亡率中的疗效。
Int J Clin Pract. 2021 May;75(5):e13970. doi: 10.1111/ijcp.13970. Epub 2021 Jan 6.
2
An internally validated prediction model for critical COVID-19 infection and intensive care unit admission in symptomatic pregnant women.针对有症状孕妇的重症 COVID-19 感染和入住重症监护病房的内部验证预测模型。
Am J Obstet Gynecol. 2022 Mar;226(3):403.e1-403.e13. doi: 10.1016/j.ajog.2021.09.024. Epub 2021 Sep 25.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
[Delta of neutrophil lymphocyte index and mortality in covid-19 disease].[新冠病毒疾病中中性粒细胞淋巴细胞比值与死亡率的关系]
Rev Med Inst Mex Seguro Soc. 2022 Oct 25;60(6):640-648.
5
Comparison of neutrophil lymphocyte ratio, platelet lymphocyte ratio, and mean platelet volume and PCR test in COVID-19 patients.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值和血小板平均体积与 PCR 检测在 COVID-19 患者中的比较。
Rev Assoc Med Bras (1992). 2021 Jul 9;67Suppl 1(Suppl 1):40-45. doi: 10.1590/1806-9282.67.Suppl1.20200630. eCollection 2021.
6
Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts.马萨诸塞州东部住院的 2019 年冠状病毒病患者中严重疾病和死亡相关的实验室检查结果。
JAMA Netw Open. 2020 Oct 1;3(10):e2023934. doi: 10.1001/jamanetworkopen.2020.23934.
7
[Investigation of the Relationship of Systemic Immune-Inflammation Index, C-Reactive Protein and Interleukin-6 with Viral Dynamics in Patients with COVID-19].[新型冠状病毒肺炎患者全身免疫炎症指数、C反应蛋白及白细胞介素-6与病毒动力学关系的研究]
Mikrobiyol Bul. 2021 Oct;55(4):539-552. doi: 10.5578/mb.20219706.
8
Neutrophil count to albumin ratio as a new predictor of mortality in patients with COVID-19 ınfection.中性粒细胞计数与白蛋白比值作为新型冠状病毒肺炎感染患者死亡率的预测指标
Rev Assoc Med Bras (1992). 2020 Sep 21;66Suppl 2(Suppl 2):77-81. doi: 10.1590/1806-9282.66.S2.77. eCollection 2020.
9
The relationship between mortality and inflammatory markers and the systemic immune inflammatory index in patients in the intensive care unit with a pneumothorax as a complication of COVID-19 disease.因 COVID-19 疾病并发气胸而入住重症监护病房的患者的死亡率与炎症标志物及全身免疫炎症指数的关系。
Ir J Med Sci. 2022 Aug;191(4):1931-1936. doi: 10.1007/s11845-021-02740-x. Epub 2021 Sep 18.
10
Predictors of Intensive Care Unit admission in patients with coronavirus disease 2019 (COVID-19).2019冠状病毒病(COVID-19)患者入住重症监护病房的预测因素
Monaldi Arch Chest Dis. 2020 Jul 15;90(3). doi: 10.4081/monaldi.2020.1410.

引用本文的文献

1
A Usefulness of Delta Neutrophil Index (DNI) for Prediction of 28 Day Mortality in Patients with Pneumonia-Induced Sepsis in the Intensive Care Unit.Delta中性粒细胞指数(DNI)对预测重症监护病房中肺炎诱发脓毒症患者28天死亡率的效用。
J Clin Med. 2025 Mar 15;14(6):2002. doi: 10.3390/jcm14062002.
2
Inflammation indices in association with periodontitis and cancer.与牙周炎和癌症相关的炎症指标。
Periodontol 2000. 2024 Oct;96(1):281-315. doi: 10.1111/prd.12612. Epub 2024 Sep 24.
3
Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis.长新冠发病机制中的线粒体氧化应激和线粒体 ROS 风暴。
Front Immunol. 2023 Dec 22;14:1275001. doi: 10.3389/fimmu.2023.1275001. eCollection 2023.
4
[Delta of neutrophil lymphocyte index and mortality in covid-19 disease].[新冠病毒疾病中中性粒细胞淋巴细胞比值与死亡率的关系]
Rev Med Inst Mex Seguro Soc. 2022 Oct 25;60(6):640-648.
5
The relationship between C-reactive protein and levels of various cytokines in patients with COVID-19: A systematic review and correlation analysis.新型冠状病毒肺炎患者C反应蛋白与多种细胞因子水平的关系:一项系统综述与相关性分析
Health Sci Rep. 2022 Oct 7;5(6):e868. doi: 10.1002/hsr2.868. eCollection 2022 Nov.
6
Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid-19 patients.淋巴细胞和单核细胞的免疫表型及 COVID-19 患者临床病程中细胞因子的状态。
J Med Virol. 2022 Oct;94(10):4744-4753. doi: 10.1002/jmv.27917. Epub 2022 Jun 13.
7
Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection.不成熟粒细胞:新型 SARS-CoV-2 感染生物标志物。
Mol Med Rep. 2022 Jul;26(1). doi: 10.3892/mmr.2022.12733. Epub 2022 May 13.
8
Can the delta neutrophil ındex be used as a preliminary biomarker ın the evaluation of periodontal disease: a pilot study.德尔塔中性粒细胞指数能否作为牙周病评估的初步生物标志物:一项初步研究。
J Appl Oral Sci. 2022 Mar 21;30:e20210555. doi: 10.1590/1678-7757-2021-0555. eCollection 2022.
9
Delta neutrophil index and C-reactive protein: a potential diagnostic marker of multisystem inflammatory syndrome in children (MIS-C) with COVID-19.Delta 中性粒细胞指数和 C 反应蛋白:COVID-19 相关儿童多系统炎症综合征(MIS-C)的潜在诊断标志物。
Eur J Pediatr. 2022 Feb;181(2):775-781. doi: 10.1007/s00431-021-04281-y. Epub 2021 Oct 14.
10
Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets.中性粒细胞与 COVID-19:积极参与者和合理的治疗靶点。
Front Immunol. 2021 Jun 2;12:680134. doi: 10.3389/fimmu.2021.680134. eCollection 2021.

本文引用的文献

1
To Study the Role of Absolute Lymphocyte Count and RDW in COVID 19 Patients and their Association with Appearance of Symptoms and Severity.研究绝对淋巴细胞计数和红细胞分布宽度在新型冠状病毒肺炎患者中的作用及其与症状出现和严重程度的关联。
J Assoc Physicians India. 2020 Aug;68(8):39-42.
2
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.概述:由 SARS-CoV-2 感染引起的肺损伤导致的全身炎症反应解释了 COVID-19 的严重结局。
Front Immunol. 2020 Jun 26;11:1626. doi: 10.3389/fimmu.2020.01626. eCollection 2020.
3
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
4
[An increased neutrophil/lymphocyte ratio is an early warning signal of severe COVID-19].中性粒细胞/淋巴细胞比值升高是重症新型冠状病毒肺炎的早期预警信号。
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Mar 30;40(3):333-336. doi: 10.12122/j.issn.1673-4254.2020.03.06.
5
Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.白细胞介素-6、C 反应蛋白和降钙素原对 COVID-19 患者的预后价值。
J Clin Virol. 2020 Jun;127:104370. doi: 10.1016/j.jcv.2020.104370. Epub 2020 Apr 14.
6
COVID-19 and the clinical hematology laboratory.新型冠状病毒肺炎与临床血液学实验室
Int J Lab Hematol. 2020 Jun;42 Suppl 1(Suppl 1):11-18. doi: 10.1111/ijlh.13229.
7
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.入院时 D-二聚体水平预测 COVID-19 患者住院死亡率。
J Thromb Haemost. 2020 Jun;18(6):1324-1329. doi: 10.1111/jth.14859.
8
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
9
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.与 2019 年冠状病毒病(COVID-19)严重疾病和死亡相关的血液学、生物化学和免疫生物标志物异常:荟萃分析。
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028. doi: 10.1515/cclm-2020-0369.
10
Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review.新型冠状病毒病 2019(COVID-19)的胸部 CT 表现:影像学综述。
Eur Radiol. 2020 Aug;30(8):4381-4389. doi: 10.1007/s00330-020-06801-0. Epub 2020 Mar 19.